Producing effective drug in order to improve the treatment of coronavirus disease (COVID-19) processes.

According to the public relations of Soha Pharmaceutical Company report:

        During the ongoing global pandemic of coronavirus disease (COVID-19), Soha in the direction of humanitarian duties as a Pharmaceutical Company tries to produce effective drug in order to improve the treatment of coronavirus disease (COVID-19) processes. Therefore, this company has produced Azithromycin 250 mg and 500 mg in capsule dosage form in the purpose of decreasing pain in coronavirus patients. In addition, currently available in distribution companies